What one share of Acro Biomedical Co. holds
Since January 30, 2017, following a change of control, our business has been the development and marketing nutritional products that promote wellness and a healthy lifestyle. Our revenue to date has resulted from the purchase of products from three suppliers in the Republic of China (Taiwan), one of which accounted for all of our purchases in the year ended December 31, 2022.
Acro Biomedical Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.00 |
| Cash and investments | $0.00 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$0.00 | — | — | — | $0.00 |
| 2016 | — | −$0.00 | — | — | — | −$0.00 |
| 2017 | $0.01 | $0.00 | — | — | — | $0.01 |
| 2018 | $0.17 | $0.01 | — | — | — | $0.03 |
| 2019 | $0.03 | −$0.01 | — | — | — | $0.02 |
| 2019 | — | −$0.01 | — | — | — | $0.02 |
| 2020 | $0.01 | −$0.00 | — | — | — | $0.01 |
| 2021 | $0.02 | −$0.14 | — | — | — | $0.01 |
| 2022 | $0.01 | −$0.26 | — | — | — | $0.01 |
| 2023 | $0.00 | −$0.15 | — | — | — | −$0.00 |
| 2024 | $0.00 | −$0.00 | — | — | — | −$0.00 |
| 2025 | $0.00 | −$0.00 | — | — | — | −$0.01 |
Common questions about Acro Biomedical Co.
How much does one share of Acro Biomedical Co. earn?
Over the last 12 months, Acro Biomedical Co. lost $0.00 for each share.
Does Acro Biomedical Co. pay a dividend?
Acro Biomedical Co. didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Acro Biomedical Co.’s book value per share?
Acro Biomedical Co.’s book value is negative (−$0.01 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Acro Biomedical Co. have?
Each share of Acro Biomedical Co. has $0.00 of cash and investments, as of June 30, 2026.
Has Acro Biomedical Co. bought back shares?
Acro Biomedical Co.’s share count rose about 38% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.